IBM Watson Health invests $50mn in research collaborations to advance use of AI in healthcare

By Laura Mullan
IBM Watson Health plans to invest $50mn in research collaborations with two academic organisations as part of a 10-year plan to advance the use of artif...

IBM Watson Health plans to invest $50mn in research collaborations with two academic organisations as part of a 10-year plan to advance the use of artificial intelligence (AI) in healthcare.

The IBM business unit will work alongside Brigham and Women's Hospital (a teaching hospital of Harvard Medical School in Boston, Massachusetts) and Vanderbilt University Medical Centre in Nashville, Tennessee.

Initially, studies are expected to see if AI could improve the use of electronic health records (EHRs) and claims data.

The research will also explore physician and patient user experience and interaction with AI technologies.

SEE ALSO:

Kyu Rhee, M.D., M.P.P., vice president and chief health officer at IBM Watson Health, said that the collaboration demonstrates IBM’s belief that working with leading institutions is the best way to “ advance, and understand practical solutions that solve some of the world's biggest health challenges”.

“Today, for example, physicians are spending an average of two hours with their electronic health records and deskwork for every hour of patient care, a phenomenon the American Medical Association says is leading to a steady increase in physician burnout,” he continued.

“AI is the most powerful technology we have today to tackle issues like this one, but there is still a great deal of work to be done to demystify the real role of AI in healthcare with practical, proven results and clear-cut best practices.”

IBM says that initial projects will focus on the practical application of AI to improve care, enhance team workflow and better understand human-machine interactions.

IBM Watson Health's vice president and chief science officer, Gretchen Purcell Jackson, added: “Our collaborative research will unlock new insights that affect broad health stakeholders: from providers, payers, governments, and life science companies to ultimately the most important stakeholder, patients, and seek to improve health around the globe."

Share

Featured Articles

Preparing for quantum: next steps for enterprise

Quantum adoption is closer to reality than we think. What should IT leaders be doing to prepare their organisations for these new capabilities?

How to strategise as a Chief Technology Officer

Chief Technology Officers (CTOs) have a wider remit than ever before. What should CTOs be prioritising as they move through 2022 and into the future?

Tech leaders say AI reads human emotions better than people

Research from RedBox was taken from UK and US tech leaders, suggesting AI can understand emotions and conversation sentiments better than humans

How will robots be used to help business?

AI & Machine Learning

Executive Q&A with Simon Wilson, CTO at Aruba UK&I

IT Procurement

Executive Q&A with Gee Rittenhouse, CEO of Skyhigh Security

Cloud & Cybersecurity